Naveta Pharma
And Vaccines Pvt. Ltd.
Pharmaceutical formulations are where Naveta Pharma's sourcing, manufacturing and merchandising work started, and they remain the most document-heavy category we handle.
Pharmaceutical formulations are where Naveta Pharma's sourcing, manufacturing and merchandising work started, and they remain the most document-heavy category we handle — every batch has to satisfy a specification, a regulatory filing, and often a destination-market labelling rule before it ever reaches a buyer. We support the full range from raw API through to a finished, market-ready pack.
We source and coordinate manufacturing for active pharmaceutical ingredients and backed by DMF and CEP documentation where the destination market requires it. Buyers get certificates of analysis and origin paperwork with every batch, not assembled after the fact once a shipment is already in transit.
Our manufacturing network covers both sterile and non-sterile dosage forms — tablets, capsules, oral liquids, injectables and topical preparations — produced in facilities designed and audited against GMP benchmarks. Facility selection is matched to the dosage form's specific requirements, since a sterile injectable line and a standard tablet line need very different utility systems and personnel flow.
Ophthalmic products carry some of the strictest sterility and stability requirements in pharmaceutical manufacturing, and we work with facilities specifically equipped and validated for this category rather than treating it as a standard liquid dosage form. Buyers sourcing ophthalmic ranges get the additional stability and sterility documentation this category typically requires.
We support generic formulations across major therapeutic categories, giving buyers access to established molecules manufactured to consistent specification. This is often the starting point for clients entering a new export market, since generics typically face a more predictable regulatory pathway than novel formulations.
For clients sourcing oncology products, we support injectable, lyophilised and oral formulation formats, working with manufacturing partners who understand the additional handling, stability and containment requirements this category carries. Documentation for oncology products is prepared to the same standard buyers would expect from a specialist oncology supplier, not a generalist treating it as just another SKU.
We also support sourcing for vaccine-adjacent categories including products used in gynaecology and assisted reproductive technology, where cold-chain handling and batch traceability matter as much as the formulation itself. We coordinate the logistics side of these categories alongside the manufacturing, since a temperature excursion in transit can undo an otherwise compliant batch.
We treat this documentation as part of the product, not an optional add-on requested after a buyer has already committed to an order.
Facility Selection: We match a formulation to a facility based on actual dosage form requirements — sterile injectables, ophthalmic and oncology each demand different validation history.
Working With Existing Product Lines: For clients who already manufacture elsewhere and are evaluating a second or backup source, we can benchmark an existing formulation and specification against our manufacturing network before committing to a switch — so a decision to change suppliers is based on a real comparison, not a sales pitch.
Start a Formulation Enquiry →